Octagon Capital Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Octagon Capital Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$1.65M	Buy
2022 Q3	–	Sell
2022 Q2	$2.26M	Hold
2022 Q1	$3.02M	Sell
2021 Q4	$7.91M	Hold
2021 Q3	$4.74M	Hold
2021 Q2	$4.91M	Hold
2021 Q1	$3.65M	Buy